全文获取类型
收费全文 | 6620篇 |
免费 | 351篇 |
国内免费 | 137篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 51篇 |
妇产科学 | 24篇 |
基础医学 | 765篇 |
口腔科学 | 85篇 |
临床医学 | 728篇 |
内科学 | 316篇 |
皮肤病学 | 41篇 |
神经病学 | 134篇 |
特种医学 | 716篇 |
外科学 | 2853篇 |
综合类 | 607篇 |
预防医学 | 82篇 |
眼科学 | 72篇 |
药学 | 187篇 |
3篇 | |
中国医学 | 119篇 |
肿瘤学 | 280篇 |
出版年
2024年 | 12篇 |
2023年 | 157篇 |
2022年 | 199篇 |
2021年 | 282篇 |
2020年 | 320篇 |
2019年 | 252篇 |
2018年 | 330篇 |
2017年 | 257篇 |
2016年 | 230篇 |
2015年 | 241篇 |
2014年 | 476篇 |
2013年 | 534篇 |
2012年 | 359篇 |
2011年 | 387篇 |
2010年 | 306篇 |
2009年 | 304篇 |
2008年 | 308篇 |
2007年 | 316篇 |
2006年 | 288篇 |
2005年 | 202篇 |
2004年 | 199篇 |
2003年 | 155篇 |
2002年 | 100篇 |
2001年 | 89篇 |
2000年 | 100篇 |
1999年 | 111篇 |
1998年 | 102篇 |
1997年 | 79篇 |
1996年 | 45篇 |
1995年 | 49篇 |
1994年 | 42篇 |
1993年 | 50篇 |
1992年 | 35篇 |
1991年 | 27篇 |
1990年 | 21篇 |
1989年 | 22篇 |
1988年 | 15篇 |
1987年 | 13篇 |
1986年 | 16篇 |
1985年 | 7篇 |
1984年 | 14篇 |
1983年 | 8篇 |
1982年 | 13篇 |
1981年 | 9篇 |
1980年 | 5篇 |
1979年 | 9篇 |
1978年 | 2篇 |
1977年 | 3篇 |
1976年 | 4篇 |
1975年 | 3篇 |
排序方式: 共有7108条查询结果,搜索用时 93 毫秒
1.
2.
BackgroundHamstring strain injuries are the most common type of injury in elite football and are associated with a high risk of reinjury, particularly those involving the intramuscular tendon (IMT). Limited information is available regarding the rehabilitation and return to sport (RTS) processes following such injuries. This case study describes the clinical presentation of an elite football player following IMT hamstring injury, their on- and off-pitch rehabilitation alongside performance monitoring throughout RTS and beyond.Case scenarioAn elite football player suffered a grade 2c hamstring injury during an English Premier League (EPL) match. The player underwent early post-injury management, alongside progressive off-pitch physical preparation. The ‘control-chaos continuum’ was used as a framework for on-pitch rehabilitation to prepare the player for a return to full team training and competition. Objective and subjective markers of the player's response to progressive on- and off-pitch loading were monitored throughout RTS and beyond.OutcomesThe player returned to on-pitch rehabilitation after 11 days, to full team training having achieved weekly pre-injury chronic running load outputs after 35 days and played in the EPL 40 days post-injury. The player did not suffer reinjury for the rest of the EPL season.ConclusionAn understanding the unique structural and mechanical properties of the IMT, alongside expected RTS timeframes are important to inform rehabilitation and decision-making processes post-injury. Performance and frequent load-response monitoring throughout RTS and beyond, in conjunction with practitioner experience and effective communication are critical in facilitating effective RTS and reduce risk of reinjury following IMT injury. 相似文献
3.
4.
5.
6.
7.
《Clinical Lymphoma, Myeloma & Leukemia》2022,22(8):608-617
BackgroundConsiderable progress has been made in therapeutic options for multiple myeloma (MM). Understanding the current landscape of MM treatment options and associated outcomes in the real world is important in providing key insights into clinical and knowledge gaps which could be targeted for further optimization.MethodsThe Canadian Myeloma Research Group Database (CMRG-DB) is a prospectively maintained disease-specific database with >7000 patients. The objective of this study was to describe the trends in the treatment landscape and outcomes including early mortality, time to next treatment, and overall survival (OS) in each line of treatment stratified by autologous stem cell transplant (ASCT) receipt among newly-diagnosed MM patients in Canada between 2007 and 2018.ResultsA total of 5154 patients were identified among which 3030 patients (58.8%) received an upfront ASCT and 2124 (41.2%) did not. At diagnosis, the median age was 64 years and 58.6% were males. Bortezomib and lenalidomide were most frequently used (>50%) in first and second-line treatment respectively among both the ASCT and non-ASCT cohort. The median OS was 122.0 months (95% Cl 115.0-135.0 months) and 54.3 months (95% CI 50.8-58.8 months) for the ASCT and non-ASCT cohort respectively with an incremental decrease in OS in each subsequent line of treatment.ConclusionWe present the largest study to date in the Canadian landscape showing the characteristics, therapy usage, and outcomes among MM patients. This information will be critical in benchmarking current outcomes and provide key insight into areas of unmet needs and gaps for improvement of MM patients nationally. 相似文献
8.
《Transfusion Clinique et Biologique》2022,29(3):224-230
The cryopreservation process of stem cells potentially cause the loss of CD34+ cells. The aim of this study is to evaluate association of patient, graft and technical characteristics with post cryopreserved CD34+ cells viability among lymphoproliferative disease namely multiple myeloma (MM) and lymphoma patients at Hospital Universiti Sains Malaysia (USM). This retrospective study was conducted in the Transplant Unit. A search of the hospital data (2008–2018) to identify 132 patients for both MM and lymphoma who underwent autologous peripheral blood haematopoietic stem cells (APBSC) mobilisation, and were successfully harvested and cryopreserved. Selected patients’ profile as well as selected parameters of stem cell mobilization and cryopreservation were obtained from laboratory information system (LIS), record unit and the Transplant Unit. Multiple logistic regression (MLR) was used to find significant associated factors and P < 0.05 was considered significant. The mean age of the patients was 39 years old with almost equal gender distribution and majority were lymphoma patients, 96 (72.7%) while 36 (27.3%) were multiple myeloma (MM) patients. The significant influencing factors of post-cryopreserved CD34+ cells viability were pre-cryopreserved CD34+ cell viability, total nucleated cells (TNC), and anti-platelet and antibiotics usage. Patients who are not on anti-platelet and have higher pre-cryopreserved CD34+ cells viability have higher chance for good post-cryopreserved CD34+ cells viability. While, those patients with higher TNC and on antibiotics have lower chance for good post cryopreserved CD34+ cells viability. This study showed patients who are not on anti-platelet and antibiotics will have higher probability of achieving good post cryopreserved CD34+ cells viability. The APBSC products with higher pre-cryopreserved CD34+ cells viability and lower TNC will achieve better post-cryopreserved CD34+ cells viability. The addition of extra plasma to the APBSC products is recommended to reduce the TNC. 相似文献
9.
《中国现代医生》2019,57(36):134-137
目的探讨甲状旁腺全切联合自体前臂移植术对肾性甲状旁腺功能亢进患者的疗效。方法回顾性分析2018年2~8月我科收治的34例肾性甲状旁腺功能亢进全麻下行甲状旁腺全切联合自体前臂移植术患者,观察其围手术期收缩压、舒张压、甲状旁腺素水平变化情况对比其术前术后脚后跟、膝关节疼痛情况,对其护理进行梳理。结果 34例患者手术后的收缩压(124.97±20.43)mmHg、舒张压(76.44±12.75)mmHg、甲状旁腺素水平(76.30±20.43)pg/mL均显著低于手术前(P0.05)。脚后跟、膝关节疼痛评估术后疼痛评分明显低于术前(P0.05)。结论甲状旁腺全切联合自体前臂移植术对肾性甲状旁腺功能亢进患者的疗效显著,能显著改善患者生活质量,而积极有效的临床护理,能保证手术的成功,减少并发症的发生。 相似文献
10.